Literature DB >> 3150628

"Free levonorgestrel index" (FLI) is a better parameter than plasma level of levonorgestrel for predicting risk of pregnancy during use of subdermal contraceptive implants releasing levonorgestrel.

S E Olsson1, V Odlind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3150628     DOI： 10.1016/0039-128x(88)90170-5

Source DB:  PubMed          Journal:  Steroids        ISSN： 0039-128X            Impact factor:   2.668


× No keyword cloud information.
  4 in total

Review 1.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

2.  Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China.

Authors:  Y Che; D Taylor; D Luo; L Y Maldonado; M Wang; S Wevill; H Vahdat; X Han; V Halpern; L Dorflinger; M J Steiner
Journal:  Contracept X       Date:  2019

3.  Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Authors:  Andrea Ries Thurman; Jill L Schwartz; Vivian Brache; Meredith R Clark; Timothy McCormick; Neelima Chandra; Mark A Marzinke; Frank Z Stanczyk; Charlene S Dezzutti; Sharon L Hillier; Betsy C Herold; Raina Fichorova; Susana N Asin; Christiane Rollenhagen; Debra Weiner; Patrick Kiser; Gustavo F Doncel
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

4.  Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic.

Authors:  M J Steiner; V Brache; D Taylor; R Callahan; V Halpern; A Jorge; S Wevill; J Sergison; L Venkatasubramanian; L Dorflinger
Journal:  Contracept X       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.